| Assessment of cannabidiol and Δ9-tetrahydrocannabiol in mouse models of medulloblastoma and ependymoma C Andradas, J Byrne, M Kuchibhotla, M Ancliffe, AC Jones, B Carline, ... Cancers 13 (2), 330, 2021 | 24 | 2021 |
| The role of cannabinoids as anticancer agents in pediatric oncology C Andradas, A Truong, J Byrne, R Endersby Cancers 13 (1), 157, 2021 | 19 | 2021 |
| Veliparib is an effective radiosensitizing agent in a preclinical model of medulloblastoma J Buck, PJC Dyer, H Hii, B Carline, M Kuchibhotla, J Byrne, M Howlett, ... Frontiers in molecular biosciences 8, 633344, 2021 | 10 | 2021 |
| In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma JP Whitehouse, H Hii, C Mayoh, M Wong, P Ajuyah, P Barahona, L Cui, ... Frontiers in Oncology 13, 1123492, 2023 | 3 | 2023 |
| BIOL-12. ENHANCING IMMUNE-MEDIATED TUMOR CONTROL IN MURINE MODELS OF GROUP 3 MEDULLOBLASTOMA Z Abbas, H Hii, J Buck, I Johnson, J Byrne, O Elaskalani, M Kuchibhotla, ... Neuro-Oncology 25 (Supplement_1), i8-i8, 2023 | | 2023 |
| Assessment of Cannabidiol and? 9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma C Andradas, J Byrne, M Kuchibhotla, M Ancliffe, AC Jones, B Carline, ... Cancers 13, 2021 | | 2021 |
| The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology. Cancers 2021, 13, 157 C Andradas, A Truong, J Byrne, R Endersby s Note: MDPI stays neu-tral with regard to jurisdictional clai-ms in …, 2021 | | 2021 |
| Supplementary Material: The Role of Cannabinoids as Anti-Cancer Agents in Paediatric Oncology C Andradas, A Truong, J Byrne, R Endersby | | |
